55566-1050 ADSTILADRIN

Product NDC:

55566-1050

Brand Name:

ADSTILADRIN

Generic Name:

Nadofaragene firadenovec-vncg

Dosage Form Name:

SUSPENSION

Administration Route:

Intravesical

Substances:

Name: NADOFARAGENE FIRADENOVEC

Strength: 300000000000.0

Unit: {VP}/mL

Packages:

Code: 55566-1050-01

Description: 4 VIAL in 1 CARTON (55566-1050-1) / 20 mL in 1 VIAL

Effective Date: July 1, 2023

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Gene Therapy

Minor Class:

IFN⍺2b

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox